Cell name:
KM-12
Other names for the model:
KM12、KM.12
Cell information:
KM-12 cells are derived from human colon cancer cells and have TPM3-NTRK1 protein fusion. Click to viewMore information.
Model information:
Subcutaneous inoculation, the mouse strain is BALB/c Nude, and matrigel needs to be added during inoculation, and DMEM without phenol red is required to prepare a cell suspension. Approximately 8 days after vaccination can be grouped, and the administration time after grouping is approximately 14 days.Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059
Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059